Skip to main content
We Study Billionaires

TIP833: Perimeter Solutions (PRM): A Niche Monopoly, One Acquisition at a Time w/ Kyle Grieve & Shawn O’Malley

75 min episode · 3 min read

Episode

75 min

Read time

3 min

Topics

Productivity, Investing, Startups

AI-Generated Summary

Key Takeaways

  • TransDigm Cloning Framework: Perimeter Solutions screens acquisitions using five criteria cloned directly from TransDigm: recurring revenue streams, long-term secular growth tailwinds, high-value yet low-cost products, high returns on tangible capital, and accretive acquisition growth. This framework targets private equity-style returns of 15% or greater annually. Investors evaluating serial acquirers should assess whether management applies a disciplined, repeatable acquisition filter rather than opportunistic deal-making.
  • Razor-Razor Blade Revenue Model: Perimeter embeds its own staff and leased equipment at over 150 air tanker bases across North America, creating a permanent infrastructure layer. Fire retardant products consumed during wildfire seasons become the recurring "blade" revenue. Services as a percentage of fire safety revenue grew from 13% in 2022 to 22% in 2025, progressively reducing cyclicality tied to annual fire season severity.
  • Specialty Products Diversification Shift: The specialty products segment jumped from roughly 25% of revenue in Q4 2025 to 63% in Q1 2026, driven primarily by the $685 million acquisition of Medical Manufacturing Technologies (MMT). MMT manufactures precision machinery—stent crimpers, catheter tube cutters—for medical device manufacturers, with initial projections of $140 million revenue and $50 million adjusted EBITDA already being exceeded in its first quarter post-close.
  • Founder Advisory Fee Distortion: Perimeter pays its founders a fee structured like a hedge fund's two-and-twenty: a fixed 1.5% annual fee in shares expiring December 2027, plus 18% of stock price appreciation above $10 expiring December 2031. In 2024 and 2025, these fees totaled $200 million and $400 million respectively, making GAAP net income negative $190 million trailing twelve months. Better stock performance paradoxically worsens reported earnings.
  • Valuation Entry Point Discipline: Using 15% revenue growth, 51% adjusted EBITDA margins, and a 17x EV/EBITDA exit multiple, the hosts calculate a base-case intrinsic value of approximately $62 per share, with a 25% margin of safety yielding a buy price near $46—representing roughly 7% returns from current prices. The hosts flag the low-to-mid $20s as a potentially attractive entry point worth monitoring for position initiation.

What It Covers

Kyle Grieve and Shawn O'Malley analyze Perimeter Solutions (PRM), a serial acquirer modeled on the TransDigm playbook, led by TransDigm founder Nicholas Howley. The episode covers PRM's two business segments—fire safety and specialty products—its acquisition strategy, founder advisory fee structure, competitive moats, key risks, and an intrinsic value estimate of $46 per share.

Key Questions Answered

  • TransDigm Cloning Framework: Perimeter Solutions screens acquisitions using five criteria cloned directly from TransDigm: recurring revenue streams, long-term secular growth tailwinds, high-value yet low-cost products, high returns on tangible capital, and accretive acquisition growth. This framework targets private equity-style returns of 15% or greater annually. Investors evaluating serial acquirers should assess whether management applies a disciplined, repeatable acquisition filter rather than opportunistic deal-making.
  • Razor-Razor Blade Revenue Model: Perimeter embeds its own staff and leased equipment at over 150 air tanker bases across North America, creating a permanent infrastructure layer. Fire retardant products consumed during wildfire seasons become the recurring "blade" revenue. Services as a percentage of fire safety revenue grew from 13% in 2022 to 22% in 2025, progressively reducing cyclicality tied to annual fire season severity.
  • Specialty Products Diversification Shift: The specialty products segment jumped from roughly 25% of revenue in Q4 2025 to 63% in Q1 2026, driven primarily by the $685 million acquisition of Medical Manufacturing Technologies (MMT). MMT manufactures precision machinery—stent crimpers, catheter tube cutters—for medical device manufacturers, with initial projections of $140 million revenue and $50 million adjusted EBITDA already being exceeded in its first quarter post-close.
  • Founder Advisory Fee Distortion: Perimeter pays its founders a fee structured like a hedge fund's two-and-twenty: a fixed 1.5% annual fee in shares expiring December 2027, plus 18% of stock price appreciation above $10 expiring December 2031. In 2024 and 2025, these fees totaled $200 million and $400 million respectively, making GAAP net income negative $190 million trailing twelve months. Better stock performance paradoxically worsens reported earnings.
  • Valuation Entry Point Discipline: Using 15% revenue growth, 51% adjusted EBITDA margins, and a 17x EV/EBITDA exit multiple, the hosts calculate a base-case intrinsic value of approximately $62 per share, with a 25% margin of safety yielding a buy price near $46—representing roughly 7% returns from current prices. The hosts flag the low-to-mid $20s as a potentially attractive entry point worth monitoring for position initiation.
  • Litigation and Concentration Risk: Over 50% of fire safety revenue comes from three customers—USDA Forest Service, US Bureau of Land Management, and the state of California—creating meaningful non-renewal and renegotiation risk. Additionally, ongoing lawsuits related to fluorine-based foam chemicals mirror cases against 3M and DuPont that resulted in multi-billion-dollar settlements, a material concern for a company with a $5.5 billion market cap.

Notable Moment

The hosts highlight a structural paradox in Perimeter's accounting: the stronger the stock performs, the worse GAAP earnings appear, because rising share prices trigger larger founder advisory fee liabilities. This counterintuitive dynamic means investors who rely on standard income statement metrics will systematically misread the business during its best-performing periods.

Know someone who'd find this useful?

Episode Transcript

You're listening to TIP. Before we get started on this business today, I I think I need an explanation. Uh-oh. That's never a good way to start an episode. So you know exactly how I feel about dilution, and this business pays fees to its founders similar to what you'd find in a two and twenty hedge fund structure, just for the privilege of owning a stock. So, what gives? Jason Brett (zero twenty seven:forty seven): Yeah. I mean, probably because the guy collecting that fee is the same guy who turned TransDigm into a compounder that outperformed the market for a couple of decades. Since 2014, with more than 200,000,000 downloads, we have interviewed the world's best investors, studied deeply the principles of value investing, and uncovered many compelling investment opportunities. We focus on understanding businesses and intrinsic value, investing accordingly, and sharing everything we learn with you. This show is not investment advice. It's intended for informational and entertainment purposes only. All opinions expressed by hosts and guests are solely their own, and they may have investments in the securities discussed. Now for your hosts, Sean O'Malley and Kyle Grieve. We have discussed many holding companies on this show and we own a few of them in our intrinsic value portfolio, businesses like Exer, E X O R, and Liftco, but you can make the argument that Amazon, Berkshire, and Google are holding companies as well, just with massive, massive business units and trillion dollar market caps. And any way you look at it, we clearly think holding companies can be good businesses as long as they're anchored by high quality assets that generate cash consistently with top notch management teams allocating capital. And so when it comes to Exeter, the main reason we own that holding company in the portfolio is because of its Ferrari stake. And so even though the other assets are just okay, the Ferrari position is, again, the real reason we own it. We get to own Ferrari shares at really a very steep discount relative to what it would cost to own the shares directly with the ticker RACE. But Kyle, I know you're a big fan of serial acquirers, which is why we also now own Liftco. And one business we don't own, however, that is probably one of the best examples of what we've been talking about because its founder Nicholas Howley was wildly successful with TransDigm and also with a company known as Perimeter Solutions. Robert Leonard (zero zero seven:thirty seven): And Nick Howley is really only the start of Perimeter Solutions superstar board and executive team. This team also includes the likes of William Thorndyke, who wrote the exceptional book that I know that you're a big fan of, Sean, The Outsiders. And he's actually also a really good investor himself with a net worth of a few $100,000,000 much of that invested specifically into the business that we'll be covering today, perimeter solutions. Then you have Tracy …

Get the full transcript (14,774 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all We Study Billionaires transcripts →

You just read a 3-minute summary of a 72-minute episode.

Get We Study Billionaires summarized like this every Monday — plus up to 2 more podcasts, free.

Pick Your Podcasts — Free

Keep Reading

More from We Study Billionaires

We summarize every new episode. Want them in your inbox?

Similar Episodes

Related episodes from other podcasts

Explore Related Topics

This podcast is featured in Best Investing Podcasts (2026) — ranked and reviewed with AI summaries.

Read this week's Investing & Markets Podcast Insights — cross-podcast analysis updated weekly.

You're clearly into We Study Billionaires.

Every Monday, we deliver AI summaries of the latest episodes from We Study Billionaires and 192+ other podcasts. Free for one show.

Start My Monday Digest

No credit card · Unsubscribe anytime